Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Hartley

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Therapeutic Innovation & Regulatory Science|January 3, 2022
Why are not There More Bayesian Clinical Trials? Perceived Barriers and Educational Preferences Among Medical Researchers Involved in Drug Development, Jennifer Clark, Natalia Muhlemann, et al.
Oral Oncology|January 9, 2019
Evidence for the approach to the diagnostic evaluation of squamous cell carcinoma occult primary tumors of the head and neckPawel Golusinski, Pasquale Di Maio, Berrin Pehlivan, et al.
British Journal of Cancer|March 29, 2023
MBTPS2 acts as a regulator of lipogenesis and cholesterol synthesis through SREBP signalling in prostate cancerAmy J Tibbo, Andrew Hartley, Richa Vasan, et al.
World Neurosurgery|February 14, 2026
Advanced MRI Techniques for Assessing Brain Metastases Response Following Stereotactic RadiosurgeryMarkand Patel, Nan Mei, Xuanxuan Li, et al.
British Journal of Cancer|January 30, 2025
Loss of ARID1A accelerates prostate tumourigenesis with a proliferative collagen-poor phenotype through co-operation with AP1 subunit cFosAndrew Hartley, Laura C A Galbraith, Robin Shaw, et al.
Frontiers in Oncology|May 16, 2018
The Clinical Utility of Cell-Free DNA Measurement in Differentiated Thyroid Cancer: A Systematic ReviewJonathan M Fussey, Jennifer L Bryant, Nikolaos Batis, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|April 4, 2023
Patient preference for commonly-used, head and neck cancer-specific quality of life questionnaires in the follow-up setting (Determin): A multi-centre randomised controlled trial and mixed methods studyHisham Mehanna, Ben Carter, Andrew Hartley, et al.
Journal of Molecular Biology|March 9, 2004
Substrate specificity and mechanism from the structure of Pyrococcus furiosus galactokinaseAndrew Hartley, Steven E Glynn, Vladimir Barynin, et al.
Head & Neck|January 11, 2016
Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trialsHisham Mehanna, Natalie Franklin, Natalie Compton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2014
A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancerGraham S Taylor, Hui Jia, Kevin Harrington, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Therapeutic Innovation & Regulatory Science|January 3, 2022
Why are not There More Bayesian Clinical Trials? Perceived Barriers and Educational Preferences Among Medical Researchers Involved in Drug Development, Jennifer Clark, Natalia Muhlemann, et al.
Oral Oncology|January 9, 2019
Evidence for the approach to the diagnostic evaluation of squamous cell carcinoma occult primary tumors of the head and neckPawel Golusinski, Pasquale Di Maio, Berrin Pehlivan, et al.
British Journal of Cancer|March 29, 2023
MBTPS2 acts as a regulator of lipogenesis and cholesterol synthesis through SREBP signalling in prostate cancerAmy J Tibbo, Andrew Hartley, Richa Vasan, et al.
World Neurosurgery|February 14, 2026
Advanced MRI Techniques for Assessing Brain Metastases Response Following Stereotactic RadiosurgeryMarkand Patel, Nan Mei, Xuanxuan Li, et al.
British Journal of Cancer|January 30, 2025
Loss of ARID1A accelerates prostate tumourigenesis with a proliferative collagen-poor phenotype through co-operation with AP1 subunit cFosAndrew Hartley, Laura C A Galbraith, Robin Shaw, et al.
Frontiers in Oncology|May 16, 2018
The Clinical Utility of Cell-Free DNA Measurement in Differentiated Thyroid Cancer: A Systematic ReviewJonathan M Fussey, Jennifer L Bryant, Nikolaos Batis, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|April 4, 2023
Patient preference for commonly-used, head and neck cancer-specific quality of life questionnaires in the follow-up setting (Determin): A multi-centre randomised controlled trial and mixed methods studyHisham Mehanna, Ben Carter, Andrew Hartley, et al.
Journal of Molecular Biology|March 9, 2004
Substrate specificity and mechanism from the structure of Pyrococcus furiosus galactokinaseAndrew Hartley, Steven E Glynn, Vladimir Barynin, et al.
Head & Neck|January 11, 2016
Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trialsHisham Mehanna, Natalie Franklin, Natalie Compton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2014
A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancerGraham S Taylor, Hui Jia, Kevin Harrington, et al.
Pageof 4